• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与因手术相关的流产相比,中国孕妇对唐氏综合征患儿出生的效用评估。

The utility assessment of Chinese pregnant women towards the birth of a baby with Down syndrome compared to a procedure-related miscarriage.

作者信息

Chan Yiu Man, Leung Tse Ngong, Leung Tak Yeung, Fung Tak Yuen, Chan Lin Wai, Lau Tze Kin

机构信息

Department of Obstetrics and Gynaecology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong.

出版信息

Prenat Diagn. 2006 Sep;26(9):819-24. doi: 10.1002/pd.1511.

DOI:10.1002/pd.1511
PMID:16832829
Abstract

OBJECTIVE

This study was performed to investigate the preferences of Chinese pregnant women for Down syndrome-affected birth compared to invasive test-related miscarriage, using the standard gamble approach, and to investigate whether there is a difference in Utility Score between general obstetric patients and those who request prenatal screening.

METHODS

An interviewer-administered survey was conducted on 67 women who presented to the General Obstetric Clinic for booking visits and 69 women who presented to the first-trimester Combined Screening Clinic for fetal Down syndrome in a University Obstetric Unit. Preferences for Down syndrome-affected birth compared to invasive test-related miscarriage were assessed using the standard gamble approach. The differences in Utility Scores for the two outcomes and difference in scores between the two study groups were compared.

RESULTS

There was no significant difference in any of the Utility Scores studied between the two study groups. Therefore the summary statistics were performed using the whole study population. The median Utility Score for a Down syndrome-birth was 0.20 (IQR: 0.10-0.40), which was significantly lower than that of 0.55 (IQR: 0.40-0.80) for a procedure-related miscarriage (p < 0.001). Also, the Utility Scores were neither found to be associated with any particular patient demographic characteristics nor their perception of the functional disability of individuals with Down syndrome.

CONCLUSION

The Chinese pregnant women in Hong Kong consider a Down syndrome-affected birth as a much worse health state and life event than a miscarriage. Whether or not to have a screening test appeared to be a result of accessibility and affordability rather than fundamental differences in attitude towards Down syndrome. The findings of the study provide important information on how prenatal screening and diagnosis of fetal chromosomal abnormalities should be offered.

摘要

目的

本研究采用标准博弈法,调查中国孕妇相较于侵入性检测相关流产,对唐氏综合征患儿出生的偏好,并调查普通产科患者与要求进行产前筛查的患者在效用得分上是否存在差异。

方法

对在大学产科单位普通产科门诊进行预约就诊的67名女性和在孕早期联合筛查门诊进行胎儿唐氏综合征筛查的69名女性进行了访谈式调查。采用标准博弈法评估相较于侵入性检测相关流产,对唐氏综合征患儿出生的偏好。比较了两种结果的效用得分差异以及两个研究组之间的得分差异。

结果

两个研究组在所研究的任何效用得分上均无显著差异。因此,使用整个研究人群进行了汇总统计。唐氏综合征患儿出生的效用得分中位数为0.20(四分位间距:0.10 - 0.40),显著低于与操作相关流产的0.55(四分位间距:0.40 - 0.80)(p < 0.001)。此外,未发现效用得分与任何特定患者人口统计学特征或他们对唐氏综合征患者功能残疾的认知相关。

结论

香港的中国孕妇认为唐氏综合征患儿出生是比流产更糟糕的健康状况和生活事件。是否进行筛查似乎是可及性和可承受性的结果,而非对唐氏综合征态度上的根本差异。该研究结果为如何提供胎儿染色体异常的产前筛查和诊断提供了重要信息。

相似文献

1
The utility assessment of Chinese pregnant women towards the birth of a baby with Down syndrome compared to a procedure-related miscarriage.与因手术相关的流产相比,中国孕妇对唐氏综合征患儿出生的效用评估。
Prenat Diagn. 2006 Sep;26(9):819-24. doi: 10.1002/pd.1511.
2
Preference assessment of prenatal diagnosis for Down syndrome: is 35 years a rational cutoff?唐氏综合征产前诊断的偏好评估:35岁作为截断值是否合理?
Prenat Diagn. 2002 Dec;22(13):1195-200. doi: 10.1002/pd.494.
3
Perceived risk of prenatal diagnostic procedure-related miscarriage and Down syndrome among pregnant women.孕妇对产前诊断程序相关流产和唐氏综合征的感知风险。
Am J Obstet Gynecol. 2008 Mar;198(3):333.e1-8. doi: 10.1016/j.ajog.2007.09.045. Epub 2008 Feb 21.
4
Miscarriage after invasive prenatal diagnostic procedures: how much risk our pregnant women are willing to take?侵入性产前诊断程序后的流产:我们的孕妇愿意承担多大风险?
Prenat Diagn. 2009 Sep;29(9):870-4. doi: 10.1002/pd.2305.
5
Women's preferences in screening for Down syndrome.女性对唐氏综合征筛查的偏好。
Prenat Diagn. 2006 Sep;26(9):837-41. doi: 10.1002/pd.1517.
6
Expectation and knowledge of women undergoing first-trimester combined screening for Down syndrome in a Chinese population.中国人群中接受孕早期唐氏综合征联合筛查的女性的期望与认知
Prenat Diagn. 2005 Dec;25(13):1248-52. doi: 10.1002/pd.1313.
7
Procedure-related miscarriages and Down syndrome-affected births: implications for prenatal testing based on women's preferences.
Obstet Gynecol. 2000 Oct;96(4):511-6. doi: 10.1016/s0029-7844(00)00969-8.
8
Do women prefer to have screening tests for Down syndrome that have the lowest screen-positive rate or the highest detection rate?女性更倾向于进行唐氏综合征筛查测试,是选择筛查阳性率最低的还是检测率最高的?
Prenat Diagn. 2003 Oct;23(10):828-32. doi: 10.1002/pd.701.
9
Pregnant women's attitudes toward amniocentesis before receiving Down syndrome screening results.孕妇在获得唐氏综合征筛查结果之前对羊膜穿刺术的态度。
Womens Health Issues. 2008 Mar-Apr;18(2):79-84. doi: 10.1016/j.whi.2007.10.003. Epub 2008 Jan 4.
10
How important is consent in maternal serum screening for Down syndrome in France? Information and consent evaluation in maternal serum screening for Down syndrome: a French study.在法国,唐氏综合征母体血清筛查中的知情同意有多重要?唐氏综合征母体血清筛查中的信息告知与知情同意评估:一项法国的研究。
Prenat Diagn. 2007 Mar;27(3):197-205. doi: 10.1002/pd.1656.

引用本文的文献

1
Offering pregnant women different levels of genetic information from prenatal chromosome microarray: a prospective study.为孕妇提供产前染色体微阵列的不同层次的遗传信息:一项前瞻性研究。
Eur J Hum Genet. 2018 Apr;26(4):485-494. doi: 10.1038/s41431-017-0084-0. Epub 2018 Feb 6.
2
"The Top Priority Is a Healthy Baby": Narratives of Health, Disability, and Abortion in Online Pregnancy Forum Discussions in the US and China.“首要任务是生出健康的宝宝”:中美在线孕期论坛讨论中的健康、残疾与堕胎叙事
J Genet Couns. 2017 Feb;26(1):32-39. doi: 10.1007/s10897-016-9976-3. Epub 2016 Jun 9.